» Articles » PMID: 29955668

Utilisation of Real-world Data from Heart Failure Registries in OECD Countries - A Systematic Review

Overview
Date 2018 Jun 30
PMID 29955668
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Heart failure represents a major public health issue that impacts 26 million people globally. Currently, real-world data represents a key instrument for providing the verification of both internal and external validity, yet there is still a lack of understanding regarding its scope in complementing evidence of treatments for heart failure. This study aims to increase understanding of the utilisation of real-word data from heart failure registries in Organisation for Economic Co-operation and Development (OECD) countries.

Method: This was a systematic review of existing observational studies from heart failure registries in 35 OECD member countries. Studies from 2000 to March 2017 were identified through electronic databases (MEDLINE (Ovid), EMBASE, Web of Science Core Collection, CINAHL (Ebsco), Cochrane CENTRAL) and appraised according to eligibility criteria.

Results: Two-hundred and two studies met the inclusion criteria, in which the majority were published from 2013 to 2016. All 202 studies were observational, among which 98% were cohort studies (198). The median sample size of all studies was 5152 (2417 to 32,890) and median study period 55 months (33.0 to 72.0). Swedish heart failure registry had the most publications (24, 12%).

Conclusion: Since 2000 there has been an upward trend in the number of published observational studies on heart failure registries in OECD countries with increasingly diverse outcomes and advanced statistical methods to improve their validity and reliability. This indicates that the utilisation of real-world data has experienced a significant upsurge in complementing the findings of clinical trials for improved research of heart failure treatments.

Citing Articles

Identification and Mapping Real-World Data Sources for Heart Failure, Acute Coronary Syndrome, and Atrial Fibrillation.

Studer R, Sartini C, Suzart-Woischnik K, Agrawal R, Natani H, Gill S Cardiology. 2021; 147(1):98-106.

PMID: 34781301 PMC: 8985014. DOI: 10.1159/000520674.


Part 1: The Wider Considerations in Translating Heart Failure Guidelines.

Iyngkaran P, Wilson A, Wong J, Prior D, Kaye D, Hare D Curr Cardiol Rev. 2021; 17(5):e160721190003.

PMID: 33423650 PMC: 8950449. DOI: 10.2174/1573403X16666210108104945.


Impact of sex differences in co-morbidities and medication adherence on outcome in 25 776 heart failure patients.

Gurgoze M, van der Galien O, Limpens M, Roest S, Hoekstra R, IJpma A ESC Heart Fail. 2020; 8(1):63-73.

PMID: 33247631 PMC: 7835621. DOI: 10.1002/ehf2.13113.


Perioperative Sleep Disturbances and Postoperative Delirium in Adult Patients: A Systematic Review and Meta-Analysis of Clinical Trials.

Wang H, Zhang L, Zhang Z, Li Y, Luo Q, Yuan S Front Psychiatry. 2020; 11:570362.

PMID: 33173517 PMC: 7591683. DOI: 10.3389/fpsyt.2020.570362.


Regional registries on the management of atrial fibrillation: Essential pieces in the global puzzle.

Gumprecht J, Lip G, Potpara T Int J Cardiol Heart Vasc. 2020; 26:100473.

PMID: 32142061 PMC: 7046532. DOI: 10.1016/j.ijcha.2020.100473.


References
1.
Oyinlola J, Campbell J, Kousoulis A . Is real world evidence influencing practice? A systematic review of CPRD research in NICE guidances. BMC Health Serv Res. 2016; 16:299. PMC: 4960862. DOI: 10.1186/s12913-016-1562-8. View

2.
Trullas J, Miro O, Formiga F, Martin-Sanchez F, Montero-Perez-Barquero M, Jacob J . The utility of heart failure registries: a descriptive and comparative study of two heart failure registries. Postgrad Med J. 2016; 92(1087):260-6. DOI: 10.1136/postgradmedj-2015-133739. View

3.
Hu C, Xing Y, Cormier J, Chang G . Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival. Cancer. 2013; 119(10):1900-7. PMC: 3673539. DOI: 10.1002/cncr.27968. View

4.
Bolli R, Chugh A, DAmario D, Loughran J, Stoddard M, Ikram S . Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet. 2011; 378(9806):1847-57. PMC: 3614010. DOI: 10.1016/S0140-6736(11)61590-0. View

5.
Garrison Jr L, Neumann P, Erickson P, Marshall D, Daniel Mullins C . Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report. Value Health. 2007; 10(5):326-35. DOI: 10.1111/j.1524-4733.2007.00186.x. View